Trial intelligence / Profile preview

Autologous bone marrow mesenchymal stem cell IV infusion for dementia (STR01-07)

jRCT1090220332Not yet recruiting

Sponsor
Chiaki Kawanishi, MD, PhD
Start
Feb 2018
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Open-label, single-arm trial of autologous bone marrow derived mesenchymal stromal cells in Dementia, sponsored by Chiaki Kawanishi, MD, PhD. Planned start Feb 2018; status: not yet recruiting.

02

Drugs

autologous bone marrow derived mesenchymal stromal cells
03

Conditions

Dementia

Beyond the preview

Go deeper on jRCT1090220332.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1090220332.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call